Nusa Konstruksi Enjiniring Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Nusa Konstruksi Enjiniring Tbk trades at Rp131 (market cap 742.52B, 2.02M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Nusa Konstruksi Enjiniring Tbk is far larger — about 2.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Nusa Konstruksi Enjiniring Tbk is more actively traded (2.02M versus 963.6K). Which is the better fit depends on your goals.
| DGIK | DGNS | |
|---|---|---|
Market Cap | 742.52B | 310.75B |
Volume | 2.02M | 963.6K |
Lot | 20.21K | 9.64K |
Turnover | 266.34M | 217.67M |
Average Price | 131.77 | 225.89 |
Value | 266.34M | 217.67M |
Indicative Equilibrium Price | 131 | 226 |
Indicative Equilibrium Volume | 119 | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Nusa Konstruksi Enjiniring Tbk formerly PT Duta Graha Indah Tbk (the company) was established on 11 Jan 1982 based on Notaries Deed No.38. The Company’s articles of association has been amended several times, most recently by notarial deed No. 21 of Mr. Haryanto, S.H., dated Sep 18, 2007, concerning among others, increase Company’s authorized stock, paid up capital and public offering of stock.
Read more on DGIK →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →